30. November 2009 by harshit.

The most recent initiative announced by the CDSCO is possibly one of the most exciting. The Ministry of Health and Family Welfare has agreed to invest close to INR250 Crore (around $50 million) in an e-governance initiative for the CDSCO to operate efficiently and transparently. Some of the e-governance initiatives contemplated include online submission of all forms, a digitalized interactive portal, digitalization of records and online approvals with digital sign. Currently, six Indian government departments have some role in approving certain aspects of drug regulations, a situation that leads to delays and a waste of resources. US-based technology solutions provider MGRM is developing a system to track and manage the complete drug regulation process. By 2013 companies are expected to be able to file and track applications online and access information concerning licensing, regulation, monitoring and even inspection audits13. Initiatives such as the central registry of volunteer fingerprints and another recently launched initiative of releasing on a daily basis, correspondence concerning drug and device companies would be accessible via the system. Internal to the CDSCO, the technology is expected smooth the interface between relevant government departments.

Posted in Uncategorized | Print | No Comments »

25. November 2009 by harshit.

It is a professional team where innovative solutions, strategies, logistics speed the early stage clinical development. Accuracy, reliability, expertise, experience and excellence characterize our delighted and committed Experts contributing to advance medical research for healthier living. Our clinical trial management services include regulatory affairs, project management, medical writing, data management, site management, safety & quality monitoring for phase I, II, III & IV trials, and bioequivalence trials At PLS every customer matters and each project is unique. Our deep knowledge of local regulatory requirement and our extensive experience with studies clinical conduct allow us to gauge how trial protocols manifest in real-life. Sponsors can therefore plan and budget based on accurate projections, they can meet their own deadlines and goals.In the complicated process of drug development, approximately 70% of the costs are incurred in clinical testing. We help our clients achieve significant cost savings and help reduce their time to market by helping them outsource their trials to India. We believe PLS offers the following edge to our global customers by operating in India. We conducted clinical studies in the following therapeutic areas but not limited to: Psychiatry and neuropsychiatry, Medical Oncology and Hematology, Medical Device study and Neurology.  PLS offers a variety of clinical studies driven by Ethics, ICH-GCP guidelines, Quality and speed

-Phase I to Phase IV clinical trials

-BA/BE studies

 Should you require any information, we’ll be pleased to assisting you: call +91-9873512366 or write to info@progressivelifesciences.com

Posted in Uncategorized | Print | No Comments »

23. November 2009 by prakash Mathew.

Protocol when goes haywire its what????

Posted in Uncategorized | Print | No Comments »

19. November 2009 by admin.

Welcome to WordPress. This is your first post. Edit or delete it, then start blogging!

Posted in Uncategorized | Print | 1 Comment »